Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase I Triazine Triepoxide (Henkel's Compound, NSC-296934)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 18								NCI-W82-0241


2.		Phase I and Pharmacologic Study of Triazine Triepoxide (NSC-296934) Administered on Single-Day and on Daily-for-5-Day Schedules

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W81-1034

Last Modified: 4/1/1989


3.		Phase I Trial of Intraperitoneal Teroxirone in Patients with Metastatic Solid Tumor Largely Confined to the Abdominal Cavity (Summary Last Modified 04/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				UMCC-8802 NCI-T88-0078C, T88-0078

Last Modified: 4/1/1991


4.		Phase I Study of Intraperitoneal Teroxirone in Patients with Advanced Malignancies Principally Confined to the Peritoneal Cavity (Summary Last Modified 04/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				MSKCC-90166 NCI-T91-0002C, T91-0002

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute